Lević M. SIGNIFICANCE OF DETERMINATION OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME. MedPodml [Internet]. 2024 Feb. 22 [cited 2026 Jul. 12];74(5):69-74. Available from: https://asistent.ceon.rs/index.php/medpod/article/view/39711